Viking Therapeutics (VKTX) Other Non-Current Assets (2014 - 2026)

Viking Therapeutics has reported Other Non-Current Assets for 13 years, with the latest figure at $211000.0 in Q2 2026.

• Quarterly Other Non-Current Assets rose 358.7% year-over-year to $211000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $211000.0 (up 358.7% YoY) and the FY2025 annual result came in at $46000.0, changed 0.0% from the prior year.
• Other Non-Current Assets improved to $211000.0 in Q2 2026 per VKTX's latest filing, from $33000.0 in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $211000.0 in Q2 2026 and troughed at $33000.0 in Q1 2022.
• A 5-year average of $47222.2 and a median of $33000.0 in 2022 frame the typical range for Other Non-Current Assets.
• The widest YoY moves for Other Non-Current Assets: up 358.7% in 2026, down 28.26% in 2026.
• Over 5 years, Other Non-Current Assets stood at $33000.0 in 2022, then changed by 0.0% to $33000.0 in 2023, then soared by 39.39% to $46000.0 in 2024, then changed by 0.0% to $46000.0 in 2025, then surged by 358.7% to $211000.0 in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $211000.0, $33000.0, and $46000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.